Information about GlobalPharmacyMeds.to
List of countries where we can ship Addyi:
Latest news releases on Addyi:
Learn how ADDYI may help premenopausal women with symptoms of acquired, generalized HSDD—low sexual desire (low libido) and associated distress.
The drug has faced criticism from those who say the F.D.A. was pressured. But advocates say the move was long overdue, given the options available to men.
FDA application and approval History for Addyi (flibanserin) supplied by Sprout Pharmaceuticals, Inc.
Flibanserin, sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD).
The U.S. Food and Drug Administration today approved Addyi (flibanserin) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.
Addyi, flibanserin, är motsvarigheten till Viagra - Men för kvinnor. Här hittar du all information om läkemedlet.
Addyi (flibanserin) is used to treat hypoactive sexual desire disorder (HSDD) in premenopausal women. Includes Addyi side effects, interactions and indications
Las autoridades estadounidenses acaban de dar luz verde al primer medicamento específico para tratar la falta de deseo sexual femenino. Respondemos a las preguntas ...
The deal for Sprout Pharmaceuticals came after the Food and Drug Administration granted approval this week for Addyi, a new libido drug for women.
But, after a few months, the market will sort out with the majority of women deciding that Addyi’s limited efficacy isn’t worth the expense and safety ...